Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000867499 | SCV001008730 | likely benign | Jeune thoracic dystrophy; Nephronophthisis | 2024-12-12 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002501268 | SCV002809437 | likely benign | Asphyxiating thoracic dystrophy 4; Nephronophthisis 12 | 2021-10-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004538255 | SCV004741504 | likely benign | TTC21B-related disorder | 2022-12-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |